212 related articles for article (PubMed ID: 14681722)
1. Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma.
Yamazaki M; Straus FH; Messina M; Robinson BG; Takeda T; Hashizume K; DeGroot LJ
Cancer Gene Ther; 2004 Jan; 11(1):8-15. PubMed ID: 14681722
[TBL] [Abstract][Full Text] [Related]
2. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ
Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724
[TBL] [Abstract][Full Text] [Related]
3. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
[TBL] [Abstract][Full Text] [Related]
4. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S
Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy.
Zhang R; DeGroot LJ
Thyroid; 2000 Apr; 10(4):313-9. PubMed ID: 10807059
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.
Shimura H; Suzuki H; Miyazaki A; Furuya F; Ohta K; Haraguchi K; Endo T; Onaya T
Cancer Res; 2001 May; 61(9):3640-6. PubMed ID: 11325833
[TBL] [Abstract][Full Text] [Related]
8. [Recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene transfer followed by ganiciclovir administration effectively inhibits growth of human small-cell lung cancer in a murine xenotransplant model].
Zhou JF; Chen G; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):68-70. PubMed ID: 15059319
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
10. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
Hall SJ; Sanford MA; Atkinson G; Chen SH
Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
Finocchiaro LM; Bumaschny VF; Karara AL; Fiszman GL; Casais CC; Glikin GC
Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
[TBL] [Abstract][Full Text] [Related]
12. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
Rancourt C; Bergeron C; Lane D; Garon G; Piché A
Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
14. Suicide gene therapy using adenovirus vector for human oral squamous carcinoma cell line in vitro.
Yamamoto N; Hayashi Y; Kagami H; Fukui T; Fukuhara H; Tohnai I; Ueda M; Mizuno M; Yoshida J
Nagoya J Med Sci; 2005 Jun; 67(3-4):83-91. PubMed ID: 17375474
[TBL] [Abstract][Full Text] [Related]
15. Ganciclovir nucleotides accumulate in mitochondria of rat liver cells expressing the herpes simplex virus thymidine kinase gene.
van der Eb MM; Geutskens SB; van Kuilenburg AB; van Lenthe H; van Dierendonck JH; Kuppen PJ; van Ormondt H; van de Velde CJ; Wanders RJ; van Gennip AH; Hoeben RC
J Gene Med; 2003 Dec; 5(12):1018-27. PubMed ID: 14661177
[TBL] [Abstract][Full Text] [Related]
16. Cell-specific induction of sensitivity to ganciclovir in medullary thyroid carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase.
Minemura K; Takeda T; Minemura K; Nagasawa T; Zhang R; Leopardi R; DeGroot LJ
Endocrinology; 2000 May; 141(5):1814-22. PubMed ID: 10803592
[TBL] [Abstract][Full Text] [Related]
17. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene.
Sieger S; Jiang S; Kleinschmidt J; Eskerski H; Schönsiegel F; Altmann A; Mier W; Haberkorn U
Cancer Gene Ther; 2004 Jan; 11(1):41-51. PubMed ID: 14681725
[TBL] [Abstract][Full Text] [Related]
19. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
20. [Effect of adenovirus-mediated TK/GCV gene therapy in combination with TNF-alpha against murine bladder cancer cells in vitro].
Shi XH; Tan WL; Zhu WH; Liang ZK; DU YJ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):750-3. PubMed ID: 18504196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
